Tolga Tanguler
Corporate Officer/Principal bei ALNYLAM PHARMACEUTICALS, INC.
Vermögen: 2 Mio $ am 31.05.2024
Aktive Positionen von Tolga Tanguler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 05.01.2021 | - |
Karriereverlauf von Tolga Tanguler
Ehemalige bekannte Positionen von Tolga Tanguler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
PFIZER, INC. | Corporate Officer/Principal | - | - |
Ferrosan Holding A/S
Ferrosan Holding A/S Specialty StoresRetail Trade Ferrosan Holding A/S offers science-based consumer healthcare products. It supplies dietary supplements and lifestyle products. The firm also acquires and holds financial assets in Ferrosan A/S. The company was founded on May 1, 1985 and is headquartered in Søborg, Denmark. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Tolga Tanguler
Michigan State University | Masters Business Admin |
Istanbul University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Dänemark | 2 |
Türkei | 2 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Ferrosan Holding A/S
Ferrosan Holding A/S Specialty StoresRetail Trade Ferrosan Holding A/S offers science-based consumer healthcare products. It supplies dietary supplements and lifestyle products. The firm also acquires and holds financial assets in Ferrosan A/S. The company was founded on May 1, 1985 and is headquartered in Søborg, Denmark. | Retail Trade |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Tolga Tanguler
- Erfahrung